Market Research Reports - Research and Markets

Welcome - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.


	Select a currency for use throughout the site

Search Results

Your Search for 'Barr: PharmaVitae Generics Profile' returned 4 results - Page 1 of 1

Teva Pharma. Industries Ltd: PharmaVitae Profile
Datamonitor, Dec 2010, Pages: 57 &A Teva is set to extend its lead due to scale advantages SWOT analysis Strengths Weaknesses Opportunities Threats ABOUT THIS PROFILE PharmaVitae Explorer database Chapter

Barr Pharmaceuticals Inc.: PharmaVitae Model
Datamonitor, March 2009, Pages: 109 acquisition by Teva, due to be completed in late 2008/early 2009 - Analyze Barr's leading position in the global market for generic oral contraceptive products CHAPTER 1 ABOUT THIS PROFILE Executive summary

Bayer Schering Pharma AG: PharmaVitae Profile
Datamonitor, June 2010, Pages: 116 enhanced the company's HealthCare division -Assess how an increased healthcare focus and merger-related synergies will drive an increase in operating profit Chapter 1 About this profile PharmaVitae

Teva Pharmaceutical Industries Ltd: PharmaVitae Model
Datamonitor, March 2009, Pages: 119 rates TABLES Table: Teva – PharmaVitae forecasts at a glance Table: Barr quarterly global sales update ($m), Q4 2008 Table: Teva key product developments, Q1–Q4 2008 Table: Teva product deals

Results:

First -

Prev -

1 -

Next -

Last

For enquiries please call us on:

+353-1-415-1241 (GMT Office Hours)

1-800-526-8630 (US/Canada Toll Free)

1-917-300-0470 (EST Office Hours)